Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | BCHE | P06276 | 7/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NOX1 | Q9Y5S8 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 2/20 | 0.33 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.33 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.33 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2419408 | 0.77 | HPGD (0.36) | MAPTNPC1HPGDMEN1KMT2A | |
| SCHEMBL3504625 | 0.67 | NPC1 (0.45) | MAOANPC1BCHENOX1MEN1 | |
| Hydrochloric Acid SCHEMBL11189563 | 0.66 | NPC1 (0.44) | MAOANPC1BCHENOX1MEN1 | |
| SCHEMBL15546491 | 0.65 | MAOA (0.39) | MAOANPC1BCHENOX1MEN1 | |
| SCHEMBL30171464 | 0.65 | MAOA (0.39) | MAOANPC1BCHENOX1MEN1 | |
| SCHEMBL15326871 | 0.65 | NPC1 (0.51) | MAOANPC1BCHENOX1MEN1 | |
| SCHEMBL23954406 | 0.64 | MAOA (0.47) | MAOABCHENOX1MEN1KMT2A | |
| SCHEMBL1343091 | 0.64 | MAOA (0.38) | MAOANPC1BCHEHPGDNOX1 | |
| SCHEMBL3055798 | 0.63 | NPC1 (0.53) | MAPTMAOANPC1BCHENOX1 | |
| SCHEMBL2057181 | 0.62 | HPGD (0.37) | HPGDADRA2ASLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1652554-B1 | Composition comprising at least one carboycanine, process of treating keratinic fibres, kit and use of said composition | OREAL (FR) | 2010-01-13 | — | — | EP | claimed |
| US-7425221-B2 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2008-09-16 | — | — | US | claimed |
| US-20060195990-A1 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2006-09-07 | — | — | US | claimed |
| EP-1652554-A1 | Composition comprising at least one carboycanine, process of treating keratinic fibres, kit and use of said composition | L'OREAL (FR) | 2006-05-03 | — | — | EP | claimed |
| WO-2006030127-A1 | COMPOSITION COMPRISING AT LEAST ONE SUBSTITUTED CARBOCYANINE DERIVATIVE, KERATIN FIBRE TREATMENT METHOD USING SAME, ASSOCIATED DEVICE AND USE THEREOF | L'OREAL (FR) | 2006-03-23 | — | — | WO | claimed |
| EP-1652554-B1 | Composition comprising at least one carboycanine, process of treating keratinic fibres, kit and use of said composition | OREAL (FR) | 2010-01-13 | — | — | EP | disclosed |
| US-7425221-B2 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2008-09-16 | — | — | US | disclosed |
| US-20060195990-A1 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | L'OREAL S.A. (FR) | 2006-09-07 | — | — | US | disclosed |
| WO-2006030127-A1 | COMPOSITION COMPRISING AT LEAST ONE SUBSTITUTED CARBOCYANINE DERIVATIVE, KERATIN FIBRE TREATMENT METHOD USING SAME, ASSOCIATED DEVICE AND USE THEREOF | L'OREAL (FR) | 2006-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060195990-A1 | Composition comprising at least one substituted derivative of carbocyanine, method for treating keratin fibers using it, device and use | KRT18, KLK5, IK | MAPT 317/4885MAOA 2267/4885NPC1 2876/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.